Propylphenidate
Systematic (IUPAC) name | |
---|---|
propyl 2-phenyl-2-(piperidin-2-yl)acetate | |
Clinical data | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | 841232-41-2 |
PubChem | CID 91844465 |
UNII | 0Q064445GT |
Chemical data | |
Formula | C16H23NO2 |
Molar mass | 261.36 g/mol |
| |
|
Propylphenidate (also known as PPH) is a piperidine based stimulant drug, closely related to methylphenidate, but with the methyl ester replaced by an propyl ester. It was banned in the UK as a Temporary Class Drug from April 2015 following its unapproved sale as a designer drug.[1] Propylphenidate can be synthesised from methylphenidate.[2]
Legal status
Propylphenidate is illegal in Sweden as of 26. January 2016.[3]
See also
- 3,4-Dichloromethylphenidate
- 4-Fluoromethylphenidate
- 4-Methylmethylphenidate
- Dexmethylphenidate
- Ethylphenidate
- Isopropylphenidate
- HDEP-28
- HDMP-28
References
- ↑ Methylphenidate-based NPS: A review of the evidence of use and harm. Advisory Council on the Misuse of Drugs, 31 March 2015
- ↑ James Alain Bourland (1997). "The influence of ethanol on drug metabolism and disposition via carboxylesterase-mediated transesterification".
- ↑ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.
This article is issued from Wikipedia - version of the Tuesday, March 22, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.